SYNGENE.NS Cash Flow
Syngene International Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 00:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹823.50 Cr. | ₹1,042.10 Cr. | ₹1,167.60 Cr. | ₹915.20 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-656.40 Cr. | ₹-495.60 Cr. | ₹-744.70 Cr. | ₹-860.40 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-342.50 Cr. | ₹-551.40 Cr. | ₹-141.80 Cr. | ₹-215.00 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹3.10 Cr. | ₹1.10 Cr. | ₹0.30 Cr. | ₹21.70 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹-172.30 Cr. | ₹-3.80 Cr. | ₹281.40 Cr. | ₹-138.50 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹261.80 Cr. | ₹89.50 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from SYNGENE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).